Search
Wednesday 27 May 2015
  • :
  • :

Losers To Keep Eyes On - Applied DNA Sciences Inc. (NASDAQ:APDN), Energy XXI Ltd. (NASDAQ:EXXI), Emerald Oil, (NYSEMKT:EOX), Encana (NYSE:ECA)

On Friday, Following Stocks were among the “Top 100 Losers” of U.S. Stock Market: Applied DNA Sciences Inc. (NASDAQ:APDN), Energy XXI Ltd. (NASDAQ:EXXI), Emerald Oil, Inc. (NYSEMKT:EOX), Encana Corporation (NYSE:ECA)

Applied DNA Sciences Inc. (NASDAQ:APDN), with shares declined -14.56%, closed at $2.70.

Energy XXI Ltd. (NASDAQ:EXXI), with shares dropped -13.37%, settled at $3.63.

Emerald Oil, Inc. (NYSEMKT:EOX), with shares dipped -11.78%, and closed at $0.760.

Encana Corporation (NYSE:ECA), plummeted -2.84%, and closed at $10.93.

Latest NEWS regarding these Stocks are depicted underneath:

Applied DNA Sciences Inc. (NASDAQ:APDN)

Applied DNA Sciences Inc. (APDN), declared that it has priced its formerly affirmed underwritten public offering of 3,820,000 shares of its ordinary stock and warrants to purchase up to an aggregate of 1,528,000shares of ordinary stock, at a combined public offering price of $3.00. The warrants have an exercise price of $3.50 per share, expire on November 20, 2019 and will trade under the symbol APDNW.

The gross proceeds to the Corporation from this offering are estimated to be about $11.46 million before deducting the underwriting discount and other estimated offering expenses. The Corporation has granted the underwriters a 45-day option to purchase an aggregate of up to 573,000 additional shares of ordinary stock and/or warrants to purchase up to 229,200 shares of ordinary stock to cover over-allotments, if any. The offering is predictable to close on or about April 1, 2015, subject to customary closing conditions.

The Corporation intends to use the net proceeds from this offering for general corporate purposes, counting working capital, capital expenditures, business development and research and development and attainments of new technologies or businesses.

Maxim Group LLC is acting as the sole book runner for the offering with The Benchmark Corporation acting as Co-Manager.

Applied DNA Sciences, Inc. provides botanical DNA-based technologies for supply chain security, brand protection, and law enforcement applications in the United States, Europe, and Asia.

Energy XXI Ltd. (NASDAQ:EXXI)

On Friday, Energy XXI Ltd. (EXXI), dropped because of the fall in oil prices.

Crude oil (WTI) was lowered by 2.57% to $50.11 per barrel and Brent crude slipped by 2.30% to $57.83 per barrel, according to the CNBC.com index.

Oil prices were in the red as concerns fade over supply disruptions in the Middle East as a result of the Saudi Arabia airstrikes in Yemen.

Energy XXI (Bermuda) Limited is engaged in the attainment, exploration, development, production, and operation of oil and natural gas properties onshore in Louisiana and Texas, and on the Gulf of Mexico.

Emerald Oil, Inc. (NYSEMKT:EOX)

Formerly on March 10, Emerald Oil, Inc. (EOX), stated a loss of $62.2 million in its fourth quarter. On a per-share basis, the Denver-based corporation said it had a loss of 92 cents. Earnings, adjusted for one-time gains and costs, came to 3 cents per share. The results met Wall Street expectations.

The independent oil and gas corporation posted proceed of $29.8 million in the period, which topped Street forecasts.

For the year, the corporation stated that its loss widened to $52.1 million, or 78 cents per share. Proceed was stated as $101.2 million.

Emerald Oil, Inc. operates as an independent oil and natural gas exploration and production corporation in the United States. The corporation designs, drills, and operates oil and natural gas wells. It primarily focuses on acquiring acreage and developing oil and natural gas wells in the Williston Basin located in North Dakota and Montana.

Encana Corporation (NYSE:ECA)

Formerly on March 20, Encana Corporation (ECA), declared that, in connection with its accomplished offering of 85,616,500 ordinary shares of Encana at a price of C$14.60 per Share, the over-allotment option granted to the underwriters to purchase up to an additional 12,842,475 Shares at the Offering Price was exercised in full for additional aggregate gross proceeds to Encana of about C$187.5 million. The sale of the additional Shares recently following the Over-Allotment Option brings the aggregate gross proceeds to Encana from the offering, counting the Over-Allotment Option (collectively, the “Offering”), to about C$1.44 billion.

Encana will use the net proceeds of the Offering to redeem its US$700 million of long-term debt maturing in 2017 and C$750 million of long-term debt maturing in 2018 on April 6, 2015. The Offering was made on a bought deal basis through a syndicate of underwriters led by RBC Capital Markets, Credit Suisse and Scotiabank.

Encana Corporation, together with its auxiliaries, engages in the development, exploration, production, and marketing of natural gas, oil, and natural gas liquids in Canada and the United States.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *